Great Point Partners LLC Infla Rx N.V. Transaction History

Great Point Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $1.3 Million - $3.08 Million	-551,918 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.03 $3.71 Million - $4.99 Million	-1,648,082 Reduced 74.91%	551,918 $1.43 Million
Q1 2021 May 17, 2021	BUY	$3.62 - $6.34 $7.96 Million - $13.9 Million	2,200,000 New	2,200,000 $8.58 Million

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $76.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.